HDAC6 and DNMT inhibition affect immunogenicity of ovarian cancer cells: A rationale for combining epigenetic and immune therapy in ovarian cancer

被引：1
|
作者：
Srivastava, Aneil P. [1 ]
Moufarrij, Sara M. [1 ]
Hadley, Melissa [1 ]
Chisholm, Sarah [1 ]
Lopez-Acevedo, Micael [1 ]
Villagra, Alejandro [1 ]
Chiappinelli, Katherine B. [1 ]
机构：
[1] George Washington Univ, Washington, DC USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1395
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1395
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Lost expression of DCC gene in ovarian cancer and its inhibition in ovarian cancer cells
    Liu Meimei
    Li Peiling
    Li Baoxin
    Li Changmin
    Zhuang Rujin
    Hu Chunjie
    MEDICAL ONCOLOGY, 2011, 28 (01) : 282 - 289
  • [32] Targeting the immune microenvironment for ovarian cancer therapy
    Blanc-Durand, Felix
    Xian, Lai Clemence Wei
    Tan, David S. P.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [33] Lost expression of DCC gene in ovarian cancer and its inhibition in ovarian cancer cells
    Liu Meimei
    Li Peiling
    Li Baoxin
    Li Changmin
    Zhuang Rujin
    Hu Chunjie
    Medical Oncology, 2011, 28 : 282 - 289
  • [34] Epigenetic regulation of interleukin-8 expression by class I HDAC and CBP in ovarian cancer cells
    Gatla, Himavanth R.
    Zou, Yue
    Uddin, Mohammad M.
    Vancurova, Ivana
    ONCOTARGET, 2017, 8 (41) : 70798 - 70810
  • [35] Epigenetic priming potentiates immune checkpoints inhibitors in ovarian cancer
    Qing, Yu
    Condello, Salvatore
    Meyer, Katie J.
    Caperell-Grant, Andrea
    Nephew, Kenneth P.
    Matei, Daniela
    CANCER RESEARCH, 2016, 76
  • [36] Epigenetic treatment of ovarian cancer cells increases immune cell recruitment to the tumor microenvironment: implications for response to immune checkpoint therapy
    Stone, Meredith L.
    Chiappinelli, Katherine B.
    Li, Huili
    Murphy, Lauren
    Topper, Michael
    Baylin, Stephen
    Zahnow, Cynthia
    CANCER RESEARCH, 2016, 76
  • [37] PARP Inhibition as Frontline Therapy in Ovarian Cancer
    Moore, Kathleen N.
    Pothuri, Bhavana
    Monk, Bradley
    Coleman, Robert L.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2020, 18 (09) : 550 - 556
  • [38] Maintenance Therapy With PARP Inhibition in Ovarian Cancer
    Herzog, Thomas J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2022, 20 (09) : 539 - 541
  • [39] Epigenetic regulation and tumorigenicity of ovarian cancer cells.
    Meng, F.
    Sun, G.
    Zhong, M.
    Yu, Y.
    Brewer, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [40] Epigenetic regulation of ARHI in breast and ovarian cancer cells
    Yu, YH
    Fujii, S
    Yuan, J
    Luo, RZ
    Wang, L
    Bao, J
    Kadota, M
    Oshimura, M
    Dent, SR
    Issa, JP
    Bast, RC
    EPIGENETICS IN CANCER PREVENTION: EARLY DETECTION AND RISK ASSESSMENT, 2003, 983 : 268 - 277
12345